Instead, some groups find evidence that the IL-23/IL-17 axis favors malignancies by spurring angiogenesis, tumor growth and the tissue remodeling associated with invasion [67]–[69], while other laboratories demonstrate a potential protective role for Th17 cells [70]–[72]. Here, IL17A is linked to neoplasm.